Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | ACACB | O00763 | 5/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 3/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.39 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL237613 | 0.81 | PTGS2 (0.56) | LDHAESR1PTGS2 | |
| SCHEMBL609670 | 0.79 | LDHA (0.44) | LDHAKMT2AMEN1PPARAELANE | |
| SCHEMBL47952 | 0.78 | RAB9A (0.56) | KMT2AMEN1THRBPPARAELANE | |
| SCHEMBL15899188 | 0.77 | PPARA (0.50) | LDHAACACBPPARAPPARGPTGS2 | |
| SCHEMBL13103842 | 0.77 | ALDH1A1 (0.59) | LDHAKMT2AMEN1PPARAPPARG | |
| SCHEMBL609925 | 0.77 | LDHA (0.43) | LDHAKMT2AMEN1ACACBPPARA | |
| SCHEMBL15899564 | 0.76 | LDHA (0.51) | LDHAKMT2AMEN1ESR1ACACB | |
| SCHEMBL237802 | 0.76 | PTGS2 (0.52) | ESR1PPARAPPARGPTGS2 | |
| SCHEMBL1219106 | 0.76 | SLC6A4 (0.59) | LDHA | |
| SCHEMBL9261658 | 0.76 | SMN1; SMN2 (0.49) | LDHAKMT2ATHRBPPARGRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7629485-B2 | Process for producing aromatic carbonate | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-12-08 | — | — | US | disclosed |
| US-20080177099-A1 | Process for Producing Aromatic Carbonate | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177099-A1 | Process for Producing Aromatic Carbonate | DCLK1, ALK, DCLK3 | LDHA 2361/4885KMT2A 2526/4885MEN1 2201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.